A1C68
4-{3-(cyanomethyl)-3-[(4M)-3',5'-dimethyl-1H,1'H-[4,4'-bipyrazol]-1-yl]azetidin-1-yl}-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide
| Created: | 2026-02-02 |
| Last modified: | 2026-06-10 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 58 |
| Chiral Atom Count | 1 |
| Bond Count | 61 |
| Aromatic Bond Count | 16 |
Chemical Component Summary | |
|---|---|
| Name | 4-{3-(cyanomethyl)-3-[(4M)-3',5'-dimethyl-1H,1'H-[4,4'-bipyrazol]-1-yl]azetidin-1-yl}-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide |
| Systematic Name (OpenEye OEToolkits) | 4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1~{H}-pyrazol-4-yl)pyrazol-1-yl]azetidin-1-yl]-2,5-bis(fluoranyl)-~{N}-[(2~{S})-1,1,1-tris(fluoranyl)propan-2-yl]benzamide |
| Formula | C23 H22 F5 N7 O |
| Molecular Weight | 507.459 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 14.52 | Cc1n[NH]c(C)c1c1cnn(c1)C1(CC#N)CN(C1)c1cc(F)c(cc1F)C(=O)NC(C)C(F)(F)F |
| SMILES | CACTVS | 3.385 | C[CH](NC(=O)c1cc(F)c(cc1F)N2CC(CC#N)(C2)n3cc(cn3)c4c(C)[nH]nc4C)C(F)(F)F |
| SMILES | OpenEye OEToolkits | 3.1.0.0 | Cc1c(c(n[nH]1)C)c2cnn(c2)C3(CN(C3)c4cc(c(cc4F)C(=O)NC(C)C(F)(F)F)F)CC#N |
| Canonical SMILES | CACTVS | 3.385 | C[C@H](NC(=O)c1cc(F)c(cc1F)N2CC(CC#N)(C2)n3cc(cn3)c4c(C)[nH]nc4C)C(F)(F)F |
| Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | Cc1c(c(n[nH]1)C)c2cnn(c2)C3(CN(C3)c4cc(c(cc4F)C(=O)N[C@@H](C)C(F)(F)F)F)CC#N |
| InChI | InChI | 1.06 | InChI=1S/C23H22F5N7O/c1-12-20(13(2)33-32-12)15-8-30-35(9-15)22(4-5-29)10-34(11-22)19-7-17(24)16(6-18(19)25)21(36)31-14(3)23(26,27)28/h6-9,14H,4,10-11H2,1-3H3,(H,31,36)(H,32,33)/t14-/m0/s1 |
| InChIKey | InChI | 1.06 | MSGYSFWCPOBHEV-AWEZNQCLSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB18855 |
|---|---|
| Name | Povorcitinib |
| Groups | investigational |
| Description | Povorcitinib is under investigation in clinical trial NCT06113445 (A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)). |
| Synonyms | Povorcitinib |
| CAS number | 1637677-22-5 |














